Skip to main content

Bill Ackman's Got A Fever And The Only Prescription Is More Takeovers

  • Author:
  • Updated:

Ackman, who has teamed up with Canadian pharmaceutical company Valeant to launch a $45.6 billion takeover of Botox maker Allergan, warned drugmakers Tuesday that he plans to go on a little buying spree. “This is not the last deal we’re going to do,” he said. “We’re already talking about the next deal we’re going to do with Valeant.” “There are $10 trillion worth of targets,” said Ackman, referring to the combined market cap of the pharmaceutical industry. “I call this the shopping list.” [NYP]


Hold Bill Ackman's Calls

The hedge fund manager is having A DAY.